awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q42369265-CFDCB99F-8F5D-4301-8E82-D16A5ABCB250
Q42369265-CFDCB99F-8F5D-4301-8E82-D16A5ABCB250
BestRank
Statement
http://www.wikidata.org/entity/statement/Q42369265-CFDCB99F-8F5D-4301-8E82-D16A5ABCB250
Efficacy and safety of nivolumab combined with standard therapies for first-line therapy of advanced non-small cell lung cancer.
P2860
Q42369265-CFDCB99F-8F5D-4301-8E82-D16A5ABCB250
BestRank
Statement
http://www.wikidata.org/entity/statement/Q42369265-CFDCB99F-8F5D-4301-8E82-D16A5ABCB250
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
003caaca08a415455d0703c8312f80e817eef4ec
P2860
Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer